Cite
HARVARD Citation
Colevas, A. et al. (n.d.). 156P A phase Ib/II study of nanatinostat (Nstat) plus valganciclovir (VGCV) in advanced Epstein-Barr virus positive (EBV+) solid tumors and with pembrolizumab (PEM) in recurrent/metastatic nasopharyngeal carcinoma (RM-NPC). Immuno-oncology technology. p. . [Online].